Lack of effect of recombinant bovine interferon alpha I1 in the treatment of experimentally-induced bovine warts.
Fifteen four-month old calves were inoculated, on five scarified sites on each side of the neck, with a suspension of ground wart tissue from a steer naturally infected with bovine papilloma virus 1. Warts started to appear about one month postinfection and were measurable in ten calves two months postinfection, when the trial started. After stratification on the size of the warts, all fifteen calves were allocated randomly to one of the following treatment groups: twice weekly intramuscular injections of 5 mg recombinant bovine interferon alpha I1 (rBoIFN alpha I1), weekly injection of 5 mg of rBoIFN alpha I1 or placebo, for three weeks. The biggest wart on each calf at the beginning of the trial was measured and photographs of all warts were taken weekly for five weeks. An analysis of covariance on the log of the volumes of warts during the five weeks of the trial showed a significant difference between groups (p = 0.026). Warts in treated groups tended to grow faster than in the placebo group.
Lassauzet
M L
ML
Ciba-Geigy S.A., Centre de Recherches Agricoles, Saint-Aubin FR, Switzerland.
Salamin
P A
PA
D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D005500:Follow-Up Studies; D007370:Interferon Type I / Q000627:therapeutic use*; D016018:Least-Squares Analysis; D008297:Male; D011994:Recombinant Proteins; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy / Q000662:veterinary*
D007370:Interferon Type I; D011994:Recombinant Proteins